SCOPUS 정보 검색 플랫폼

Volumn 248, Issue 1-2, 2001, Pages 103-111

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies

(8) Stockmeyer, Bernhard a Elsässer, David a Dechant, Michael a Repp, Roland a Gramatzki, Martin a Glennie, Martin J b Van De Winkel, Jan G J c Valerius, Thomas a

a UNIVERSITY OF ERLANGEN NUREMBERG (Germany)

b UNIVERSITY OF SOUTHAMPTON (United Kingdom)

c UNIVERSITY MEDICAL CENTER UTRECHT (Netherlands)

Author keywords

Antibody therapy; Bispecific antibody; Colony stimulating factors; Fc receptors; Granulocytes

Indexed keywords

ANTIBODY CD 16; ANTIBODY CD 64; ANTIBODY CD 89; BISPECIFIC ANTIBODY; FC RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RITUXIMAB; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFICACY; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; PRIORITY JOURNAL; REFLEX RECRUITMENT;

EID: 0035251734 PISSN: 00221759 EISSN: None Source Type: Journal
DOI: 10.1016/S0022-1759(00)00346-X Document Type: Review

Times cited : (64)

References (26)

1
- 0032127350
- Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
- (1998) Cancer Res. , vol.58 , pp. 2825-2831
- Baselga, J.¹ Norton, L.² Albanell, J.³ Kim, Y.M.⁴ Mendelsohn, J.⁵

2
- 0034076307
- Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets
- (2000) Nature Med. , vol.6 , pp. 443-446
- Clynes, R.A.¹ Towers, T.L.² Presta, L.G.³ Ravetch, J.V.⁴

3
- 0032143550
- Antibody engineering
- (1998) Curr. Opin. Struct. Biol. , vol.8 , pp. 443-450
- Dall'Acqua, W.¹ Carter, P.²

4
- 0031106547
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies
- (1997) Immunol. Today , vol.18 , pp. 127-135
- Deo, Y.M.¹ Graziano, R.F.² Repp, R.³ Van de Winkel, J.G.J.⁴

5
- 0035863830
- The intriguing role of polymorphonuclear neutrophils in antitumor reactions
- in press
- (2001) Blood 97
- Di Carlo, E.¹ Forni, G.² Lollini, P.³ Colombo, M.P.⁴ Modesti, A.⁵ Musiani, P.⁶

6
- 0000097822
- 3 antibody derivatives
- Gallagher, G., Rees, R.C., Reynolds, C.W., (Eds.), Tumor Immunobiology: A Practical Approach. Oxford University Press, Oxford
- (1995) , pp. 225-244
- Glennie, M.J.¹ Tutt, A.L.² Greenman, J.³

7
- 13344259328
- Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice
- (1996) J. Clin. Invest. , vol.97 , pp. 331-338
- Heijnen, I.A.¹ Van Vugt, M.J.² Fanger, N.A.³ Graziano, R.F.⁴ De Wit, T.P.⁵ Hofhuis, F.M.⁶ Guyre, P.M.⁷ Capel, P.J.⁸ Verbeek, J.S.⁹ Van de Winkel, J.G.J.¹⁰

8
- 0034668385
- Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B cell lymphoma
- (2000) Blood , vol.96 , pp. 3544-3552
- Honeychurch, J.¹ Tutt, A.L.² Valerius, T.³ Heijnen, I.A.F.M.⁴ Van de Winkel, J.G.J.⁵ Glennie, M.J.⁶

9
- 0029063667
- Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2
- (1995) Cancer Res. , vol.55 , pp. 2627-2634
- Hooijberg, E.¹ Sein, J.J.² Van den Berk, P.C.³ Hart, A.A.⁴ Van der Valk, M.A.⁵ Kast, W.M.⁶ Melief, C.J.⁷ Hekman, A.⁸

10
- 0034081614
- Monoclonal antibody therapies: A 'constant' threat to cancer
- (2000) Nature Med. , vol.6 , pp. 373-374
- Houghton, A.N.¹ Scheinberg, D.A.²

11
- 0022648483
- Surface phenotype and function of tonsillar germinal center and mantle zone B cell subsets
- (1986) Hum. Immunol. , vol.15 , pp. 30-43
- Ledbetter, J.A.¹ Clark, E.A.²

12
- 0345337254
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
- (1998) J. Clin. Oncol. , vol.16 , pp. 2825-2833
- McLaughlin, P.¹ Grillo-Lopez, A.J.² Link, B.K.³ Levy, R.⁴ Czuczman, M.S.⁵ Williams, M.E.⁶ Heyman, M.R.⁷ Bence-Bruckler, I.⁸ White, C.A.⁹ Cabanillas, F.¹⁰ Jain, V.¹¹ Ho, A.D.¹² Lister, J.¹³ Wey, K.¹⁴ Shen, D.¹⁵ Dallaire, B.K.¹⁶

13
- 0000212829
- Overall survival advantage to simultaneous chemotherapy plus the humanized anti-HER2 monoclonal antibody herceptin in HER-2-overexpressing metastatic breast cancer
- (1999) Proc. Am. Soc. Clin. Oncol. , vol.18
- Norton, L.¹ Slamon, D.² Leyland-Jones, B.³ Wolter, J.⁴ Flemming, T.⁵ Eirmann, W.⁶ Baselga, J.⁷ Mendelsohn, J.⁸ Bajamonde, A.⁹ Maureen, A.¹⁰ Shak, S.¹¹

14
- 0024493315
- Human hemopoietic growth factors
- (1989) Eur. J. Hematol. , vol.42 , pp. 1-15
- Platzer, E.¹

15
- 0032882746
- Bispecific antibodies in cancer therapy
- (1999) Curr. Opin. Immunol. , vol.11 , pp. 558-562
- Segal, D.M.¹ Weiner, G.J.² Weiner, L.M.³

16
- 0032030699
- Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies
- (1998) Blood , vol.91 , pp. 1644-1652
- Shan, D.¹ Ledbetter, J.A.² Press, O.W.³

17
- 0032851961
- Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)
- (1999) Semin. Oncol. , vol.26 , pp. 60-70
- Sliwkowski, M.X.¹ Lofgren, J.A.² Lewis, G.D.³ Hotaling, T.E.⁴ Fendly, B.M.⁵ Fox, J.A.⁶

18
- 0000350976
- Chemically engineered chimeric and multi-Fab antibodies
- Clark, M. (Ed.), Protein Engineering of Antibody Molecules. Academic Titles, Nottingham, UK
- (1993) , pp. 127-138
- Stevenson, G.T.¹ Glennie, M.J.² Kan, K.S.³

19
- 0034670004
- Triggering Fcα-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy
- (2000) J. Immunol. , vol.165 , pp. 5954-5961
- Stockmeyer, B.¹ Dechant, M.² Van Egmond, M.³ Tutt, A.L.⁴ Sudarapandiyan, K.⁵ Graziano, R.F.⁶ Repp, R.⁷ Kalden, J.R.⁸ Gramatzki, M.⁹ Glennie, M.J.¹⁰ Van de Winkel, J.G.J.¹¹ Valerius, T.¹²

20
- 0030613845
- FcαRI (CD89) as a novel trigger molecule for bispecific antibody therapy
- (1997) Blood , vol.90 , pp. 4485-4492
- Valerius, T.¹ Stockmeyer, B.² Van Spriel, A.B.³ Graziano, R.F.⁴ Van den Herik Oudijk, I.E.⁵ Repp, R.⁶ Deo, Y.M.⁷ Lund, J.⁸ Kalden, J.R.⁹ Gramatzki, M.¹⁰ Van de Winkel, J.G.J.¹¹

21
- 0030726820
- Activated neutrophils as effector cells for bispecific antibodies
- (1997) Cancer Immunol. Immunother. , vol.45 , pp. 142-145
- Valerius, T.¹ Würflein, D.² Stockmeyer, B.³ Repp, R.⁴ Kalden, J.R.⁵ Gramatzki, M.⁶

22
- 0033564274
- Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ-chain and CR3 (CD11b/CD18)
- (1999) Blood , vol.93 , pp. 4387-4394
- Van Egmond, M.¹ Van Vuuren, A.J.² Morton, H.C.³ Van Spriel, A.B.⁴ Shen, L.⁵ Hofhuis, F.M.⁶ Saito, T.⁷ Mayadas, T.N.⁸ Verbeek, J.S.⁹ Van de Winkel, J.G.J.¹⁰

23
- 0005942493
- Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy
- in press
- (2000) Crit. Rev. Oncol. Uernatol.
- Van Ojik, H.H.¹ Valerius, T.²

24
- 0033859727
- Immunotherapeutic perspective for bispecific antibodies
- (2000) Immunol. Today , vol.21 , pp. 391-397
- Van Spriel, A.B.¹ Van Ojik, H.H.² Van de Winkel, J.G.J.³

25
- 0032851960
- An overview of monoclonal antibody therapy of cancer
- (1999) Semin. Oncol. , vol.26 , pp. 41-50
- Weiner, L.M.¹

26
- 2642651103
- Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells
- (1998) Cancer Res. , vol.58 , pp. 3051-3058
- Würflein, D.¹ Dechant, M.² Stockmeyer, B.³ Tutt, A.L.⁴ Hu, P.⁵ Repp, R.⁶ Kalden, J.R.⁷ Van de Winkel, J.G.J.⁸ Epstein, A.L.⁹ Valerius, T.¹⁰ Glennie, M.¹¹ Gramatzki, M.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.